During the past 3 years of EUnetHTA’s operations in the framework of the Joint Action 2, an expanded suite of practical approaches and tools for HTA production has been developed and tested through a series of field-testing exercises in EUnetHTA, both in the framework of joint assessments and by individual European HTA organisations in their local HTA processes. The detailed results of these activities will be included in the final technical report to the European Commission (to be delivered in May 2016).<br><br>
The EUnetHTA Evidence Submission Template is one such practical tool. Available in both short and long versions for pharmaceuticals as well as medical devices, the Submission Template is a flexible tool that reflects all national evidence requirements for reimbursement in Europe within the HTA Core Model® four domains: health problem and current use of technology, description and technical characteristics of the technology, safety, and clinical effectiveness. The inclusion of all national evidence requirements means that the submission template can be broadly applied to national and/or joint assessment.<br><br>
The flexibility of the submission template allows HTA agencies to – according to need – add, remove and adapt questions and provide further information to aid completion of the template by the technology developers that are required to submit evidence in support of their technology’s value claims. A set of adaptation notes have been created to support HTA agencies with the process of tailoring the tool’s content.<br><br>
The suite of the EUnetHTA Evidence Submission Template tools, as well as a report describing the national evidence requirements for reimbursement is available here.
